Peter Zimetbaum

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

Nicholas J. Mercuro, Christina Yen, David Shim et al. · JAMA Cardiology · 2020 · 720 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction

Paul Sorajja, Bernard J. Gersh, DA Cox et al. · European Heart Journal · 2007 · 525 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Treatment of Obstructive Sleep Apnea Reduces the Risk of Atrial Fibrillation Recurrence After Catheter Ablation

Adam S. Fein, Alexei Shvilkin, Dhaval Shah et al. · Journal of the American College of Cardiology · 2013 · 437 citations

Medicine, Cardiology, Internal Medicine +15

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States

Karin S. Coyne, Clark Paramore, Susan Grandy et al. · Value in Health · 2006 · 425 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +12

Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device

Mintu P. Turakhia, Donald D. Hoang, Peter Zimetbaum et al. · The American Journal of Cardiology · 2013 · 260 citations · Full text

Medicine, Cardiology, Internal Medicine +16